BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34131101)

  • 1. MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma.
    Liu Y; Zhang Y; Xiao B; Tang N; Hu J; Liang S; Pang Y; Xu H; Ao J; Yang J; Liang X; Wei L; Wang Y; Luo X
    Cell Death Dis; 2021 Jun; 12(6):618. PubMed ID: 34131101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.
    Zhu H; Zhang H; Pei Y; Liao Z; Liu F; Su C; Liu Y; Dong R; Song J; Zhang X; Fan Y; Liang H; Zhang B; Chen X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):57. PubMed ID: 33541391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
    Zou Y; Sun Z; Sun S
    J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.
    Yang C; Ma X; Guan G; Liu H; Yang Y; Niu Q; Wu Z; Jiang Y; Bian C; Zang Y; Zhuang L
    FASEB J; 2019 Jan; 33(1):1456-1467. PubMed ID: 30130435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
    Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
    Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346.
    Bai N; Peng E; Qiu X; Lyu N; Zhang Z; Tao Y; Li X; Wang Z
    J Exp Clin Cancer Res; 2018 Jul; 37(1):172. PubMed ID: 30053867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
    Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-802 accelerates hepatocellular carcinoma growth by targeting RUNX3.
    Ni M; Zhao Y; Zhang WJ; Jiang YJ; Fu H; Huang F; Li DJ; Shen FM
    J Cell Physiol; 2020 Oct; 235(10):7128-7135. PubMed ID: 32003017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.